Jeffrey L. Cleland
- Pharmaceutical Science top 0.1%
- Advanced Drug Delivery Systems 9
- Biomaterials top 1%
- Molecular Biology top 1%
- Protein purification and stability 27
- Protein Structure and Dynamics 5
-
- Monoclonal and Polyclonal Antibodies Research 15
- Molecular Medicine top 2%
-
- Growth Hormone and Insulin-like Growth Factors 13
-
- Immunotherapy and Immune Responses 8
-
- Pancreatic function and diabetes 7
-
- HIV Research and Treatment 6
- Co-authors
- Theodore W. RandolphAnn L. DaughertyAndrew J. S. JonesJohn F. CarpenterXanthe M. LamDaniel I. C. WangEileen DuenasEllen Filvaroff
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Journal of Biological Chemistry (3 papers)Nature Medicine (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Jeffrey L. Cleland
82 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Pharmaceutical Science 1.3k
- Biomaterials 908
- Molecular Biology 4.2k
- Radiology, Nuclear Medicine and Imaging 1.2k
- Molecular Medicine 219
Countries citing papers authored by Jeffrey L. Cleland
This map shows the geographic impact of Jeffrey L. Cleland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey L. Cleland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey L. Cleland more than expected).
Fields of papers citing papers by Jeffrey L. Cleland
This network shows the impact of papers produced by Jeffrey L. Cleland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey L. Cleland. The network helps show where Jeffrey L. Cleland may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jeffrey L. Cleland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 62 | |
| 2 | An Injectable Depot Formulation of an Outflow Prodrug for Sustained Reduction of Intraocular Pressure | 2018 | 1 |
| 3 | Sunitinib-Loaded Injectable Polymer Depot Formulation for Potential Once per Year Treatment of Neovascular Age-related Macular Degeneration (wet AMD) | 2018 | 1 |
| 4 | Modifications of Sunitinib-Loaded GB-102 Microparticles that Lengthen Drug Release: 9-Months Ocular Tolerability and PK in Rabbit Following IVT Dosing | 2017 | 2 |
| 5 | GB-102 for Wet AMD: A Novel Injectable Formulation that Safely Delivers Active Levels of Sunitinib to the Retina and RPE/Choroid for Over Four Months | 2016 | 8 |
| 6 | 2009 | 38 | |
| 7 | The targeted cytotoxic prodrug, AQ4N, persists in the spleen, large intestine, and subcutaneous tumors | 2005 | 0 |
| 8 | 2001 | 171 | |
| 9 | 2000 | 13 | |
| 10 | 1998 | 35 | |
| 11 | 1998 | 143 | |
| 12 | 1997 | 87 | |
| 13 | 1997 | 193 | |
| 14 | 1997 | 24 | |
| 15 | Protein engineering : principles and practice | 1996 | 85 |
| 16 | 1996 | 26 | |
| 17 | 1996 | 248 | |
| 18 | 1996 | 73 | |
| 19 | 1995 | 37 | |
| 20 | 1992 | 149 |
About Jeffrey L. Cleland
Jeffrey L. Cleland is a scholar working on Pharmaceutical Science, Virology and Radiology, Nuclear Medicine and Imaging, having authored 84 papers that have together received 6.8k indexed citations. Recurring topics across this work include Protein purification and stability (27 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Growth Hormone and Insulin-like Growth Factors (13 papers), Advanced Drug Delivery Systems (9 papers), Immunotherapy and Immune Responses (8 papers), Pancreatic function and diabetes (7 papers), HIV Research and Treatment (6 papers) and Protein Structure and Dynamics (5 papers). The work is most often cited by research in Pharmaceutical Science (1.3k citations), Biomaterials (908 citations) and Molecular Biology (4.2k citations). Jeffrey L. Cleland has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Theodore W. Randolph, Ann L. Daugherty, Andrew J. S. Jones, John F. Carpenter, Xanthe M. Lam, Daniel I. C. Wang, Eileen Duenas, Ellen Filvaroff, Brent S. Kendrick and Hope Steinmetz. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.